Summary
Updated Aug 30, 2026
Jeanne Thoma is Director of ANI PHARMACEUTICALS INC (ANIP). 4 SEC Form 4 filings on record going back to 2024, most recently on 11 June 2026. Most recent open-market trade: sold $1.30M of ANIP on 18 August 2025. Lifetime open-market sales: $1.92M.
Recent Transactions
5Every recent SEC Form 4 transaction Jeanne Thoma has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeanne Thoma files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nikhil Lalwani - $4.67M of ANIP open-market activity in the last 12 months
- Patrick D. Walsh - $2.32M of ANIP open-market activity in the last 12 months
- Christopher Mutz - $1.64M of ANIP open-market activity in the last 12 months
- Stephen P. Carey - $1.57M of ANIP open-market activity in the last 12 months
- Chad Gassert - $1.31M of ANIP open-market activity in the last 12 months
- Krista Davis - $883K of ANIP open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jeanne Thoma?
Jeanne Thoma is a corporate insider, tracked as Director of ANI PHARMACEUTICALS INC (ANIP). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jeanne Thoma submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jeanne Thoma been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($1.92M) across all tracked filings.
Where can I see all of Jeanne Thoma's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jeanne Thoma and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
